Eisai Co., Ltd. today announced the latest findings on etalanetug (development code: E2814) showed that this investigational ...

An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.

Genomic alterations as predictive biomarkers for cancer-associated thrombosis (CAT) in biliary tract cancer (BTC). This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...

Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...

To improve ovarian cancer screening, researchers led by Johns Hopkins University’s Victor E. Velculescu, MD, PhD, developed a combination liquid biopsy approach. It has three components: measurements ...

Middle-aged adults with positive plasma biomarkers for Alzheimer disease show accelerated decline in specific cognitive domains.

New biomarker analyses from the phase 3 KEYNOTE-522 trial provide insights into the biological factors that may influence response to pembrolizumab plus chemotherapy in early-stage triple-negative ...

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced positive ...

Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage Detection GAITHERSBURG, Md., July 09, 2026 (GLOBE NEWSWIRE) -- 20/20 ...